Home
IMNM
IMNM News

Latest Immunome Inc. (IMNM) News on July 26, 2024

Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities

Business Wire

a day ago

Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities

Immunome Insiders Added US$2.67m Of Stock To Their Holdings

Simply Wall St.

7 days ago

Immunome Insiders Added US$2.67m Of Stock To Their Holdings

Immunome Appoints Phil Tsai as Chief Technical Officer

Business Wire

a month ago

Immunome Appoints Phil Tsai as Chief Technical Officer

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 05/22/2024

Insider Buying: Immunome Inc's CEO Acquires 100,000 Shares

GuruFocus.com

2 months ago

Insider Buying: Immunome Inc's CEO Acquires 100,000 Shares

MT Newswires

2 months ago

Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing

MT Newswires

2 months ago

Immunome Completes Purchase of Antibodies From Atreca

Immunome Announces Completion of Purchase of Assets from Atreca

Business Wire

2 months ago

Immunome Announces Completion of Purchase of Assets from Atreca

MT Newswires

2 months ago

Immunome Appoints Max Rosett as CFO

Immunome Announces Promotion of Max Rosett to Chief Financial Officer

Business Wire

2 months ago

Immunome Announces Promotion of Max Rosett to Chief Financial Officer

Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Revenue Estimates

Zacks

2 months ago

Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Revenue Estimates

Immunome Reports First Quarter 2024 Financial Results and Provides Business Update

Business Wire

2 months ago

Immunome Reports First Quarter 2024 Financial Results and Provides Business Update

Immunome to Present at 2024 Bank of America Healthcare Conference

Business Wire

3 months ago

Immunome to Present at 2024 Bank of America Healthcare Conference

Immunome Appoints Kinney Horn as Chief Business Officer

Business Wire

3 months ago

Immunome Appoints Kinney Horn as Chief Business Officer

MT Newswires

3 months ago

--JPMorgan Starts Immunome With Overweight Rating, $24 Price Target

Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for

Immunome Appoints Sandra M. Swain to Board of Directors

Business Wire

3 months ago

Immunome Appoints Sandra M. Swain to Board of Directors

Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting

Business Wire

4 months ago

Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting

New Strong Sell Stocks for April 4th

Zacks

4 months ago

New Strong Sell Stocks for April 4th

Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets

Business Wire

4 months ago

Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets

Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala

Business Wire

4 months ago

Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

GlobeNewswire

4 months ago

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

Immunome, Inc. (NASDAQ:IMNM) surges 7.6%; individual investors who own 42% shares profited along with institutions

Simply Wall St.

4 months ago

Immunome, Inc. (NASDAQ:IMNM) surges 7.6%; individual investors who own 42% shares profited along with institutions

Business Wire

5 months ago

Immunome to Participate in the Leerink Partners Global Biopharma Conference

Business Wire

5 months ago

Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference

Business Wire

5 months ago

Immunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors

Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors

GlobeNewswire

5 months ago

Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors

Business Wire

5 months ago

Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Business Wire

5 months ago

Immunome Announces Pricing of Public Offering of Common Stock

Business Wire

5 months ago

Immunome Announces Proposed Public Offering of Common Stock

Insiders See US$1.25m Investment In Immunome Jump Last Week

Simply Wall St.

6 months ago

Insiders See US$1.25m Investment In Immunome Jump Last Week

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

Zacks

6 months ago

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

Business Wire

6 months ago

Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals

Business Wire

6 months ago

Immunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

WEBINAR INVITATION | Okeanis Eco Tankers, Corp. (NYSE: ECO) (OSLO: OET) Live Investor Webinar on Friday, February 2, 2024 at 9:00 am ET

GlobeNewswire

6 months ago

WEBINAR INVITATION | Okeanis Eco Tankers, Corp. (NYSE: ECO) (OSLO: OET) Live Investor Webinar on Friday, February 2, 2024 at 9:00 am ET

SpartanNash Recognized by Newsweek as One of America's Greatest Workplaces for Diversity 2024

PR Newswire

6 months ago

SpartanNash Recognized by Newsweek as One of America's Greatest Workplaces for Diversity 2024

Here's Why Bank of America Is a No-Brainer Dividend Stock

Motley Fool

6 months ago

Here's Why Bank of America Is a No-Brainer Dividend Stock

Q3 Earnings Outperformers: Shake Shack (NYSE:SHAK) And The Rest Of The Modern Fast Food Stocks

StockStory

6 months ago

Q3 Earnings Outperformers: Shake Shack (NYSE:SHAK) And The Rest Of The Modern Fast Food Stocks

15 Best Jewelry Insurance Companies Heading into 2024

Insider Monkey

6 months ago

15 Best Jewelry Insurance Companies Heading into 2024

Associated Press Finance

6 months ago

Veritex Holdings: Q4 Earnings Snapshot

Veritex Holdings, Inc. Declares Cash Dividend on Common Stock

GlobeNewswire

6 months ago

Veritex Holdings, Inc. Declares Cash Dividend on Common Stock

Atrion (NASDAQ:ATRI) investors are sitting on a loss of 54% if they invested five years ago

Simply Wall St.

6 months ago

Atrion (NASDAQ:ATRI) investors are sitting on a loss of 54% if they invested five years ago

Personal Care Stocks Q3 Recap: Benchmarking Herbalife (NYSE:HLF)

StockStory

6 months ago

Personal Care Stocks Q3 Recap: Benchmarking Herbalife (NYSE:HLF)

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

StockStory

6 months ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

11 Stocks That Will Make You Rich in 5-10 Years

Insider Monkey

6 months ago

11 Stocks That Will Make You Rich in 5-10 Years

Diebold Nixdorf Sets Out to Combat Shrink in Retail with New AI-powered Offering

PR Newswire

6 months ago

Diebold Nixdorf Sets Out to Combat Shrink in Retail with New AI-powered Offering

Reuters

6 months ago

Exclusive-Netsmart's owners explore a sale valuing it at $5 billion -sources

3 REITs with Yields over 6%

Benzinga

6 months ago

3 REITs with Yields over 6%

Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently

Insider Monkey

6 months ago

Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently

ProPetro Announces Fourth Quarter 2023 Earnings Call

Business Wire

6 months ago

ProPetro Announces Fourth Quarter 2023 Earnings Call

Lithium Argentina Announces 2023 Production Results for Caucharí-Olaroz

GlobeNewswire

7 months ago

Lithium Argentina Announces 2023 Production Results for Caucharí-Olaroz

Veradigm Inc (MDRX) Issues Refreshed Fiscal 2023 Financial Estimates

GuruFocus.com

7 months ago

Veradigm Inc (MDRX) Issues Refreshed Fiscal 2023 Financial Estimates

We're Not Very Worried About SecureWorks' (NASDAQ:SCWX) Cash Burn Rate

Simply Wall St.

7 months ago

We're Not Very Worried About SecureWorks' (NASDAQ:SCWX) Cash Burn Rate

Why Fast-paced Mover Greenbrier (GBX) Is a Great Choice for Value Investors

Zacks

7 months ago

Why Fast-paced Mover Greenbrier (GBX) Is a Great Choice for Value Investors

Business Wire

7 months ago

Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform

Kymera Therapeutics Announces Proposed Public Offering

GlobeNewswire

7 months ago

Kymera Therapeutics Announces Proposed Public Offering

Business Wire

7 months ago

Immunome Appoints Phil Roberts as Chief Technical Officer

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

GlobeNewswire

7 months ago

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Business Wire

7 months ago

Immunome to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

7 months ago

Immunome Appoints Carol A. Schafer to Board of Directors

These Stocks Moved the Most Today: RayzeBio, Gracell, NIO, Intel, Manchester United, FedEx, Arm, and More

Barrons.com

7 months ago

These Stocks Moved the Most Today: RayzeBio, Gracell, NIO, Intel, Manchester United, FedEx, Arm, and More

Reuters

7 months ago

US STOCKS-Wall Street ends higher in final stretch of 2023, rate cuts in view

AstraZeneca to Acquire Gracell in $1.2 Billion Deal to Further Cell Therapy Goals

Barrons.com

7 months ago

AstraZeneca to Acquire Gracell in $1.2 Billion Deal to Further Cell Therapy Goals

AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies

Benzinga

7 months ago

AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies

Business Wire

7 months ago

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

GlobeNewswire

7 months ago

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

Estimating The Intrinsic Value Of SecureWorks Corp. (NASDAQ:SCWX)

Simply Wall St.

7 months ago

Estimating The Intrinsic Value Of SecureWorks Corp. (NASDAQ:SCWX)

3 Lower-Priced REITs With Higher Yields Seeing Renewed Buying

Benzinga

7 months ago

3 Lower-Priced REITs With Higher Yields Seeing Renewed Buying

Getty Realty Corp. Announces 2023 Getty Gives Activity

Business Wire

7 months ago

Getty Realty Corp. Announces 2023 Getty Gives Activity

Suburban Propane Stock Hits 80-Plus RS Rating, Has Big Price Swing

Investor's Business Daily

7 months ago

Suburban Propane Stock Hits 80-Plus RS Rating, Has Big Price Swing

Canada Goose Appoints Beth Clymer as President, Finance, Strategy & Administration

Business Wire

7 months ago

Canada Goose Appoints Beth Clymer as President, Finance, Strategy & Administration

HCI Group Insurance Subsidiary Assumes $30 Million of In-Force Premium from Citizens, Consolidated In-Force Premium Reaches $1 Billion

GlobeNewswire

7 months ago

HCI Group Insurance Subsidiary Assumes $30 Million of In-Force Premium from Citizens, Consolidated In-Force Premium Reaches $1 Billion

Shareholders in Hanesbrands (NYSE:HBI) are in the red if they invested three years ago

Simply Wall St.

7 months ago

Shareholders in Hanesbrands (NYSE:HBI) are in the red if they invested three years ago

JELD-WEN Holding, Inc. (NYSE:JELD) Screens Well But There Might Be A Catch

Simply Wall St.

7 months ago

JELD-WEN Holding, Inc. (NYSE:JELD) Screens Well But There Might Be A Catch

Ero Copper Corp.'s (TSE:ERO) 36% Jump Shows Its Popularity With Investors

Simply Wall St.

7 months ago

Ero Copper Corp.'s (TSE:ERO) 36% Jump Shows Its Popularity With Investors

12 Extreme Dividend Stocks With Upside Potential

Insider Monkey

7 months ago

12 Extreme Dividend Stocks With Upside Potential

3 Oil and Gas Stocks to Buy for High Dividends and Growth in December 2023

InvestorPlace

7 months ago

3 Oil and Gas Stocks to Buy for High Dividends and Growth in December 2023

Microcap Funds Are Super-Cheap. Why They Could Deliver Big Returns in 2024.

Barrons.com

7 months ago

Microcap Funds Are Super-Cheap. Why They Could Deliver Big Returns in 2024.

Guild Mortgage Names Adam O’Daniel SVP and CMO

Business Wire

8 months ago

Guild Mortgage Names Adam O’Daniel SVP and CMO

Sterling Launches Enhanced Capabilities in Asia Pacific Region

GlobeNewswire

8 months ago

Sterling Launches Enhanced Capabilities in Asia Pacific Region

Should We Be Cautious About Distribution Solutions Group, Inc.'s (NASDAQ:DSGR) ROE Of 0.8%?

Simply Wall St.

8 months ago

Should We Be Cautious About Distribution Solutions Group, Inc.'s (NASDAQ:DSGR) ROE Of 0.8%?

Ero Copper Completes US$111 Million Bought Deal Financing

GlobeNewswire

8 months ago

Ero Copper Completes US$111 Million Bought Deal Financing

Sterling Check Corp. (NASDAQ:STER) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Sterling Check Corp. (NASDAQ:STER) Q3 2023 Earnings Call Transcript

Business Wire

9 months ago

Immunome to Present at the Stifel 2023 Healthcare Conference

Business Wire

9 months ago

Immunome Reports Third Quarter 2023 Financial Results

XPEL Inc (XPEL) Reports Double-Digit Revenue Growth in Q3 2023

GuruFocus.com

9 months ago

XPEL Inc (XPEL) Reports Double-Digit Revenue Growth in Q3 2023

Distribution Solutions Group, Inc. (NASDAQ:DSGR) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Distribution Solutions Group, Inc. (NASDAQ:DSGR) Q3 2023 Earnings Call Transcript

Share on Social Networks: